These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 19658274

  • 1. The effect of hypermagnesemic treatment on cerebrospinal fluid magnesium level in patients with aneurysmal subarachnoid hemorrhage.
    Wong GK, Lam CW, Chan MT, Gin T, Poon WS.
    Magnes Res; 2009 Jun; 22(2):60-5. PubMed ID: 19658274
    [Abstract] [Full Text] [Related]

  • 2. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS).
    Al-Tamimi YZ, Bhargava D, Feltbower RG, Hall G, Goddard AJ, Quinn AC, Ross SA.
    Stroke; 2012 Mar; 43(3):677-82. PubMed ID: 22282887
    [Abstract] [Full Text] [Related]

  • 3. Intravenous Hydrogen Therapy With Intracisternal Magnesium Sulfate Infusion in Severe Aneurysmal Subarachnoid Hemorrhage.
    Takeuchi S, Kumagai K, Toyooka T, Otani N, Wada K, Mori K.
    Stroke; 2021 Jan; 52(1):20-27. PubMed ID: 33349011
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, Kunze E, Matthies C, Ernestus RI, Solymosi L, Roosen K.
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [Abstract] [Full Text] [Related]

  • 5. Effects of magnesium sulfate infusion on cerebral perfusion in patients after aneurysmal SAH.
    Wong GK, Kwok R, Tang K, Yeung D, Ahuja A, King AD, Poon WS.
    Acta Neurochir Suppl; 2010 May; 106():133-5. PubMed ID: 19812935
    [Abstract] [Full Text] [Related]

  • 6. Plasma magnesium concentrations and clinical outcomes in aneurysmal subarachnoid hemorrhage patients: post hoc analysis of intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage trial.
    Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, Zee BC.
    Stroke; 2010 Aug; 41(8):1841-4. PubMed ID: 20538692
    [Abstract] [Full Text] [Related]

  • 7. Intracellular free magnesium of brain and cerebral phosphorus-containing metabolites after subarachnoid hemorrhage and hypermagnesemic treatment: a ³¹P–magnetic resonance spectroscopy study. Clinical article.
    Wong GK, Yeung DK, Ahuja AT, King AD, Lam CW, Chan MT, Gin T, Poon WS.
    J Neurosurg; 2010 Oct; 113(4):763-9. PubMed ID: 19911890
    [Abstract] [Full Text] [Related]

  • 8. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.
    Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, Zee BC, IMASH Investigators.
    Stroke; 2010 May; 41(5):921-6. PubMed ID: 20378868
    [Abstract] [Full Text] [Related]

  • 9. The effect of intravenous magnesium sulfate infusion on serum levels of sodium and potassium in patients with aneurysmal subarachnoid hemorrhage.
    Wong GK, Poon WS, Chan MT, Boet R, Gin T, Lam CW.
    Magnes Res; 2007 Mar; 20(1):37-42. PubMed ID: 17536487
    [Abstract] [Full Text] [Related]

  • 10. Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea.
    Wong GK, Chan MT, Poon WS, Boet R, Gin T.
    Neurol Res; 2006 Jun; 28(4):431-5. PubMed ID: 16759446
    [Abstract] [Full Text] [Related]

  • 11. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: current status.
    Wong GK, Chan MT, Gin T, Poon WS.
    Acta Neurochir Suppl; 2011 Jun; 110(Pt 2):169-73. PubMed ID: 21125466
    [Abstract] [Full Text] [Related]

  • 12. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ.
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid and serum chitotriosidase levels in patients with aneurysmal subarachnoid haemorrhage: preliminary results.
    Işman FK, Kacira T, Kuçur M, Sanus GZ, Atukeren P, Tanriverdi T, Kaynar MY.
    Turk Neurosurg; 2007 Oct; 17(4):235-42. PubMed ID: 18050064
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Magnesium sulfate for aneurysmal subarachnoid hemorrhage: the end of the road or more trials?
    Vergouwen MD.
    Crit Care; 2011 Oct; 15(2):140. PubMed ID: 21489317
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia.
    McKee JA, Brewer RP, Macy GE, Phillips-Bute B, Campbell KA, Borel CO, Reynolds JD, Warner DS.
    Crit Care Med; 2005 Mar; 33(3):661-6. PubMed ID: 15753761
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis.
    Wong GK, Boet R, Poon WS, Chan MT, Gin T, Ng SC, Zee BC.
    Crit Care; 2011 Mar; 15(1):R52. PubMed ID: 21299874
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.